Transforming Healthcare at the Nanoscale
Cutting-edge DNA nanorobot technology meets groundbreaking applications, ranging from diagnostics to novel RNA therapeutics. At Nanovery, we are pioneering the future of healthcare with our innovative platform that enables precise, efficient, and cost-effective detection and quantification of nucleic acids. Our DNA nanorobots operate at the nanoscale to identify specific biomarkers, facilitating early diagnosis and improved patient outcomes. With significant investments and collaborations, Nanovery is at the forefront of transforming healthcare and drug development.
Where our technology can help
Drug safety
Bioanalysis
RNA diagnostics
Infectious diseases
Cell therapy
Gene therapy
RNA therapeutics
VaccinesBioanalysis of ASOs
Our cutting-edge DNA nanorobot technology excels in the bioanalysis of antisense oligonucleotides (ASOs) and small interfering RNA (siRNA). These synthetic molecules are pivotal in gene therapy, gene silencing, and gene modulation. Nanovery’s nanorobots enable precise detection and quantification of ASOs and siRNA in complex biological samples, ensuring accurate and reliable results with minimal preparation time. This advanced capability supports the development and optimisation of therapies targeting various diseases, providing researchers with the tools they need to achieve groundbreaking advancements.
Custom Assay Development
Nanovery offers bespoke assay development tailored to meet your specific research and bioanalysis needs. Our expert team collaborates with clients to design and implement assays that leverage the unique capabilities of our DNA nanorobot platform to detect ASOs and siRNA, providing unparalleled sensitivity and specificity for a wide range of applications.
Why choose Nanovery’s NANs technology?
Works directly in complex biological media
Unmatched accuracy in real-world conditions.
Signal amplification at room temperature
Streamlining the analysis process.
Entirely enzyme-free and completely homogenous
Reducing the risk of contamination and error.
Simple and cost-efficient protocol using plate readers
Making advanced testing accessible.
Speak with our Expert
microRNA Biomarkers
microRNAs are critical biomarkers for various diseases, including cancer. Nanovery’s technology allows for the precise detection and quantification of select microRNAs, facilitating early diagnosis and monitoring of disease progression. Our platform ensures reliable results with robust assays and quick turnaround times, eliminating the need for specialized staff or equipment. This accessibility and efficiency provide valuable insights into disease mechanisms and potential therapeutic targets, making our technology an essential tool in modern diagnostics.
miRometer-122™ Assay Kit
(coming soon)
Nanovery’s upcoming miRometer-122™ Assay Kit represents a significant advancement in microRNA analysis. Designed to detect miR-122, a biomarker associated with liver diseases, this kit will provide researchers and clinicians with a powerful tool for early diagnosis and treatment monitoring. The miRometer-122™ Assay Kit combines Nanovery’s patented nanorobot technology with an easy-to-use format, ensuring fast and accurate results.
- Collect sample
- Add miRometer™
- Measure fluorescence
